Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.

Osawa S, Kumabe T, Saito R, Sonoda Y, Niizuma H, Watanabe M, Tominaga T.

Brain Tumor Pathol. 2011 Apr;28(2):167-74. doi: 10.1007/s10014-010-0014-0. Epub 2011 Jan 6.

PMID:
21210238
2.

Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.

Breitfeld PP, Lyden E, Raney RB, Teot LA, Wharam M, Lobe T, Crist WM, Maurer HM, Donaldson SS, Ruymann FB.

J Pediatr Hematol Oncol. 2001 May;23(4):225-33.

PMID:
11846301
3.

Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.

Urban C, Benesch M, Pakisch B, Lackner H, Kerbl R, Schwinger W, Oberbauer R.

J Neurooncol. 1998 Aug;39(1):71-80.

PMID:
9760072
4.
5.

Treatment of children with nonmetastatic paratesticular rhabdomyosarcoma: results of the Malignant Mesenchymal Tumors studies (MMT 84 and MMT 89) of the International Society of Pediatric Oncology.

Stewart RJ, Martelli H, Oberlin O, Rey A, Bouvet N, Spicer RD, Godzinski J, Stevens MC; International Society of Pediatric Oncology.

J Clin Oncol. 2003 Mar 1;21(5):793-8.

PMID:
12610176
6.

Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.

Hagemeister FB.

Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. Epub 2002 Apr 12. Review.

PMID:
12042984
7.

Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.

Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, Atlas MP, Gonzalez-Gomez I, Miller D, Finlay JL.

Pediatr Blood Cancer. 2008 Mar;50(3):715-7.

PMID:
17009232
8.

[Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].

Häberle B, Bode U, von Schweinitz D.

Klin Padiatr. 2003 May-Jun;215(3):159-65. German.

PMID:
12778356
9.

Adult medulloblastoma: multiagent chemotherapy.

Greenberg HS, Chamberlain MC, Glantz MJ, Wang S.

Neuro Oncol. 2001 Jan;3(1):29-34. Review.

10.

Neuroblastoma.

Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.

Saudi Med J. 2001 Aug;22(8):674-80.

PMID:
11573111
11.

Primary pineal rhabdomyosarcoma successfully treated by high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation: case report.

Ishi Y, Yamaguchi S, Iguchi A, Cho Y, Ohshima J, Hatanaka KC, Takakuwa E, Kobayashi H, Terasaka S, Houkin K.

J Neurosurg Pediatr. 2016 Jul;18(1):41-5. doi: 10.3171/2015.12.PEDS15419. Epub 2016 Mar 4. Review.

PMID:
26942266
12.

[Pediatric rhabdomyosarcoma of the infratemporal fossa].

Rozan O, Janot F, Oberlin O, Schwaab G, Quintana E, Tran Ba Huy P, Georges B, Luboinski B.

Ann Otolaryngol Chir Cervicofac. 2002 Sep;119(4):195-201. French.

13.

Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.

Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe MJ, van Unnik A, Quintana E, Stevens MC.

J Clin Oncol. 2005 Jul 1;23(19):4363-71.

PMID:
15994146
14.

Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.

Raney RB, Anderson JR, Barr FG, Donaldson SS, Pappo AS, Qualman SJ, Wiener ES, Maurer HM, Crist WM.

J Pediatr Hematol Oncol. 2001 May;23(4):215-20. Review.

PMID:
11846299
15.

Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.

Horibe K, Fukuda M, Miyajima Y, Matsumoto K, Kondo M, Inaba J, Miyashita Y.

Med Pediatr Oncol. 2001 Jan;36(1):203-4.

PMID:
11464885
16.

Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.

Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.

J BUON. 2006 Oct-Dec;11(4):433-8.

PMID:
17309174
17.

Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.

Chamberlain MC, Glantz MJ.

Neurosurgery. 2008 Oct;63(4):720-6; author reply 726-7. doi: 10.1227/01.NEU.0000325494.69836.51.

PMID:
18981882
18.

Does consolidation with autologous stem cell transplantation improve the outcome of children with metastatic or relapsed Ewing sarcoma?

Al-Faris N, Al Harbi T, Goia C, Pappo A, Doyle J, Gassas A.

Pediatr Blood Cancer. 2007 Aug;49(2):190-5.

PMID:
17262797
19.

Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.

Luksch R, Tienghi A, Hall KS, Fagioli F, Picci P, Barbieri E, Gandola L, Eriksson M, Ruggieri P, Daolio P, Lindholm P, Prete A, Bisogno G, Tamburini A, Grignani G, Abate ME, Podda M, Smeland S, Ferrari S.

Ann Oncol. 2012 Nov;23(11):2970-6. doi: 10.1093/annonc/mds117. Epub 2012 Jul 5.

PMID:
22771824
20.

An approach for cure: PEI-chemotherapy and regional deep hyperthermia in children and adolescents with unresectable malignant tumors.

Wessalowski R, Schneider DT, Mils O, Hannen M, Calaminus G, Engelbrecht V, Pape H, Willers R, Engert J, Harms D, Göbel U.

Klin Padiatr. 2003 Nov-Dec;215(6):303-9.

PMID:
14677093

Supplemental Content

Support Center